Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) Receives $38.00 Consensus Target Price from Brokerages
Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA – Get Free Report) has been assigned a consensus rating of “Buy” from the five analysts that are covering the firm, MarketBeat reports. Five equities research analysts have rated the stock with a buy rating. The average 1-year price objective among brokerages that have covered the stock in the last year […]
Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA – Get Free Report) has been assigned a consensus rating of “Buy” from the five analysts that are covering the firm, MarketBeat reports. Five equities research analysts have rated the stock with a buy rating. The average 1-year price objective among brokerages that have covered the stock in the last year […]
